{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:02:56Z","timestamp":1771524176935,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Regulation of enhancer activity plays a pivotal role in governing gene expression and cellular behaviors. However, the precise mechanisms underlying dynamic control of active enhancers remain incompletely defined. Here, we demonstrate that the nuclear receptor estrogen-related receptor \u03b1 (ERR\u03b1) forms a functional complex with the H3K4me3-specific demethylase KDM5C to co-occupy a large set of active enhancers, including the locus of STING. In breast cancer cells, ERR\u03b1 depletion induces STING enhancer hyperactivation, evidenced by H3K4me3 deposition, decreased H3K4me1, and increased enhancer RNA (eRNA) transcription. Accordingly, depletion of ERR\u03b1 leads to further activation of STING gene transcription and TBK1-IRF3 pathway, accompanied by increased type I interferon (IFN) and IFN-stimulated gene (ISG) expression, as confirmed by transcriptomic analysis. Notably, depleting ERR\u03b1 markedly attenuates breast tumor cell growth in vitro and in vivo, and our in vitro evidence indicates this occurs in part through activating STING signaling. These findings establish that the ERR\u03b1-KDM5C serves as a critical checkpoint for STING enhancer activity, revealing a regulatory mechanism of STING enhancer activity in breast tumor progression.<\/jats:p>","DOI":"10.1038\/s41419-026-08499-2","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T18:15:57Z","timestamp":1771438557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ERR\u03b1-KDM5C restrains STING enhancer activity to modulate type I interferon signaling in breast cancer progression"],"prefix":"10.1038","volume":"17","author":[{"given":"Zu-Hui","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Fa","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Gui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1321-5793","authenticated-orcid":false,"given":"Juan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3434-4162","authenticated-orcid":false,"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-8383","authenticated-orcid":false,"given":"Xiao-Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-5192","authenticated-orcid":false,"given":"Wen-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"8499_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"8499_CR2","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","volume":"14","author":"M Esteller","year":"2024","unstructured":"Esteller M, Dawson MA, Kadoch C, Rassool FV, Jones PA, Baylin SB. The epigenetic hallmarks of cancer. Cancer Discov. 2024;14:1783\u2013809.","journal-title":"Cancer Discov"},{"key":"8499_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev-biochem-011420-095916","volume":"89","author":"A Field","year":"2020","unstructured":"Field A, Adelman K. Evaluating enhancer function and transcription. Annu Rev Biochem. 2020;89:213\u201334.","journal-title":"Annu Rev Biochem"},{"key":"8499_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrc.2016.62","volume":"16","author":"I Sur","year":"2016","unstructured":"Sur I, Taipale J. The role of enhancers in cancer. Nat Rev Cancer. 2016;16:483\u201393.","journal-title":"Nat Rev Cancer"},{"key":"8499_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature09033","volume":"465","author":"TK Kim","year":"2010","unstructured":"Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465:182\u20137.","journal-title":"Nature"},{"key":"8499_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nature10006","volume":"474","author":"D Wang","year":"2011","unstructured":"Wang D, Garcia-Bassets I, Benner C, Li W, Su X, Zhou Y, et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature. 2011;474:390\u20134.","journal-title":"Nature"},{"key":"8499_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.molcel.2013.01.038","volume":"49","author":"E Calo","year":"2013","unstructured":"Calo E, Wysocka J. Modification of enhancer chromatin: What, how, and why? Mol Cell. 2013;49:825\u201337.","journal-title":"Mol Cell"},{"key":"8499_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2017.07.007","volume":"170","author":"JS Roe","year":"2017","unstructured":"Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, et al. Enhancer reprogramming promotes pancreatic cancer metastasis. Cell. 2017;170:875\u201388.e20.","journal-title":"Cell"},{"key":"8499_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cell.2015.01.006","volume":"160","author":"D Villar","year":"2015","unstructured":"Villar D, Berthelot C, Aldridge S, Rayner TF, Lukk M, Pignatelli M, et al. Enhancer evolution across 20 mammalian species. Cell. 2015;160:554\u201366.","journal-title":"Cell"},{"key":"8499_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934\u201347.","journal-title":"Cell"},{"key":"8499_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320\u201334.","journal-title":"Cell"},{"key":"8499_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature10805","volume":"482","author":"WA Whyte","year":"2012","unstructured":"Whyte WA, Bilodeau S, Orlando DA, Hoke HA, Frampton GM, Foster CT, et al. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature. 2012;482:221\u20135.","journal-title":"Nature"},{"key":"8499_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ng.3167","volume":"47","author":"S Pott","year":"2015","unstructured":"Pott S, Lieb JD. What are super-enhancers? Nat Genet. 2015;47:8\u201312.","journal-title":"Nat Genet"},{"key":"8499_CR14","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/emboj.2011.295","volume":"30","author":"A Pekowska","year":"2011","unstructured":"Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F, Holota H, et al. H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J. 2011;30:4198\u2013210.","journal-title":"EMBO J"},{"key":"8499_CR15","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ng.3142","volume":"46","author":"LJ Core","year":"2014","unstructured":"Core LJ, Martins AL, Danko CG, Waters CT, Siepel A, Lis JT. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat Genet. 2014;46:1311\u201320.","journal-title":"Nat Genet"},{"key":"8499_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1101\/gad.309351.117","volume":"32","author":"T Henriques","year":"2018","unstructured":"Henriques T, Scruggs BS, Inouye MO, Muse GW, Williams LH, Burkholder AB, et al. Widespread transcriptional pausing and elongation control at enhancers. Genes Dev. 2018;32:26\u201341.","journal-title":"Genes Dev"},{"key":"8499_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2016.02.064","volume":"165","author":"H Shen","year":"2016","unstructured":"Shen H, Xu W, Guo R, Rong B, Gu L, Wang Z, et al. Suppression of enhancer overactivation by a RACK7-histone demethylase complex. Cell. 2016;165:331\u201342.","journal-title":"Cell"},{"key":"8499_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.cell.2007.02.017","volume":"128","author":"S Iwase","year":"2007","unstructured":"Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH, et al. The X-linked mental retardation gene SMCX\/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell. 2007;128:1077\u201388.","journal-title":"Cell"},{"key":"8499_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nature05823","volume":"447","author":"M Tahiliani","year":"2007","unstructured":"Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature. 2007;447:601\u20135.","journal-title":"Nature"},{"key":"8499_CR20","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.cell.2025.02.023","volume":"188","author":"ZH Gray","year":"2025","unstructured":"Gray ZH, Honer MA, Ghatalia P, Shi Y, Whetstine JR. 20 years of histone lysine demethylases: from discovery to the clinic and beyond. Cell. 2025;188:1747\u201383.","journal-title":"Cell"},{"key":"8499_CR21","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1073\/pnas.0914818107","volume":"107","author":"JA Smith","year":"2010","unstructured":"Smith JA, White EA, Sowa ME, Powell ML, Ottinger M, Harper JW, et al. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci USA. 2010;107:3752\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8499_CR22","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-17-2118","volume":"78","author":"X Chen","year":"2018","unstructured":"Chen X, Loo JX, Shi X, Xiong W, Guo Y, Ke H, et al. E6 protein expressed by high-risk HPV activates super-enhancers of the EGFR and c-MET oncogenes by destabilizing the histone demethylase KDM5C. Cancer Res. 2018;78:1418\u201330.","journal-title":"Cancer Res"},{"key":"8499_CR23","doi-asserted-by":"publisher","first-page":"11422","DOI":"10.1111\/jcmm.15746","volume":"24","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li X, Zhang J, Mao L. E6 hijacks KDM5C\/lnc_000231\/miR-497-5p\/CCNE1 axis to promote cervical cancer progression. J Cell Mol Med. 2020;24:11422\u201333.","journal-title":"J Cell Mol Med"},{"key":"8499_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3389\/fonc.2020.01025","volume":"10","author":"B Zhang","year":"2020","unstructured":"Zhang B, Zhou BH, Xiao M, Li H, Guo L, Wang MX, et al. KDM5C represses FASN-mediated lipid metabolism to exert tumor suppressor activity in intrahepatic cholangiocarcinoma. Front Oncol. 2020;10:1025.","journal-title":"Front Oncol"},{"key":"8499_CR25","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.7150\/thno.60233","volume":"11","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Li P, Zhou X, Qiang Y, Fan J, Lin Y, et al. Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis. Theranostics. 2021;11:8674\u201391.","journal-title":"Theranostics"},{"key":"8499_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s42003-025-07695-8","volume":"8","author":"M Muller","year":"2025","unstructured":"Muller M, Zodel K, Abhari BA, Cuomo F, Nizamuddin S, Metzger P, et al. KDM5C and KDM5D mutations have different consequences in clear cell renal cell carcinoma cells. Commun Biol. 2025;8:244.","journal-title":"Commun Biol"},{"key":"8499_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40618-021-01606-4","volume":"45","author":"Y Wang","year":"2022","unstructured":"Wang Y, Ye H, Yang Y, Li J, Cen A, Zhao L. microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C. J Endocrinol Investig. 2022;45:17\u201328.","journal-title":"J Endocrinol Investig"},{"key":"8499_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05296-5","volume":"13","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Wang CY, Gao C, Chen JD, Chen JJ, Wang Z, et al. Regulation of KDM5C stability and enhancer reprogramming in breast cancer. Cell Death Dis. 2022;13:843.","journal-title":"Cell Death Dis"},{"key":"8499_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41375-023-01810-6","volume":"37","author":"ML Trempenau","year":"2023","unstructured":"Trempenau ML, Schuster MB, Pundhir S, Pereira MA, Kalvisa A, Tapia M, et al. The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes. Leukemia. 2023;37:593\u2013605.","journal-title":"Leukemia"},{"key":"8499_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108793","volume":"114","author":"Z Hong","year":"2019","unstructured":"Hong Z, Wu G, Xiang ZD, Xu CD, Huang SS, Li C, et al. KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN. Biomed Pharmacother. 2019;114:108793.","journal-title":"Biomed Pharmacother"},{"key":"8499_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2023.05.007","volume":"138","author":"AL Lemster","year":"2023","unstructured":"Lemster AL, Weingart A, Bottner J, Perner S, Sailer V, Offermann A, et al. Elevated PSPC1 and KDM5C expression indicates poor prognosis in prostate cancer. Hum Pathol. 2023;138:1\u201311.","journal-title":"Hum Pathol"},{"key":"8499_CR32","doi-asserted-by":"crossref","unstructured":"Lemster AL, Sievers E, Pasternack H, Lazar-Karsten P, Kl\u00fcmper N, Sailer V, et al. Histone demethylase KDM5C drives prostate cancer progression by promoting EMT. Cancers. 2022;14:1894.","DOI":"10.3390\/cancers14081894"},{"key":"8499_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.535449","volume":"10","author":"H Lin","year":"2020","unstructured":"Lin H, Ma N, Zhao L, Yang G, Cao B. KDM5c promotes colon cancer cell proliferation through the FBXW7-c-Jun Regulatory Axis. Front Oncol. 2020;10:535449.","journal-title":"Front Oncol"},{"key":"8499_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10735-020-09921-5","volume":"52","author":"H Gu","year":"2021","unstructured":"Gu H, Lin R, Zheng F, Zhang Q. ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784\/KDM5C axis. J Mol Histol. 2021;52:31\u201344.","journal-title":"J Mol Histol"},{"key":"8499_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004635","volume":"8","author":"HF Shen","year":"2021","unstructured":"Shen HF, Zhang WJ, Huang Y, He YH, Hu GS, Wang L, et al. The dual function of KDM5C in both gene transcriptional activation and repression promotes breast cancer cell growth and tumorigenesis. Adv Sci. 2021;8:2004635.","journal-title":"Adv Sci"},{"key":"8499_CR36","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s00432-021-03684-6","volume":"147","author":"J Liu","year":"2021","unstructured":"Liu J, Zhu M, Tang Q. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C. J Cancer Res Clin Oncol. 2021;147:2867\u201377.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8499_CR37","first-page":"30","volume":"39","author":"Y Cui","year":"2022","unstructured":"Cui Y, Lv C, Wen Y, Zhao D, Yang Y, Qiu H, et al. HOXD3 up-regulating KDM5C promotes malignant progression of diffuse large B-cell lymphoma by decreasing p53 expression. Balkan Med J. 2022;39:30\u20138.","journal-title":"Balkan Med J"},{"key":"8499_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02475-4","volume":"22","author":"KL Liu","year":"2022","unstructured":"Liu KL, Yin YW, Lu BS, Niu YL, Wang DD, Shi B, et al. E2F6\/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter. Cancer Cell Int. 2022;22:109.","journal-title":"Cancer Cell Int"},{"key":"8499_CR39","doi-asserted-by":"crossref","unstructured":"Drongitis D, Verrillo L, De Marinis P, Orabona P, Caiola A, Turitto G, et al. The chromatin-oxygen sensor gene KDM5C associates with novel hypoxia-related signatures in glioblastoma multiforme. Int J Mol Sci. 2022;23:10250.","DOI":"10.3390\/ijms231810250"},{"key":"8499_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.celrep.2017.09.014","volume":"21","author":"M Scandaglia","year":"2017","unstructured":"Scandaglia M, Lopez-Atalaya JP, Medrano-Fernandez A, Lopez-Cascales MT, Del Blanco B, Lipinski M, et al. Loss of Kdm5c causes spurious transcription and prevents the fine-tuning of activity-regulated enhancers in neurons. Cell Rep. 2017;21:47\u201359.","journal-title":"Cell Rep"},{"key":"8499_CR41","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1158\/0008-5472.CAN-23-2888","volume":"84","author":"Y Qiang","year":"2024","unstructured":"Qiang Y, Fan J, Xie C, Yan L, Song X, Zhang N, et al. KDM5C-mediated recruitment of BRD4 to chromatin regulates enhancer activation and BET inhibitor sensitivity. Cancer Res. 2024;84:1252\u201369.","journal-title":"Cancer Res"},{"key":"8499_CR42","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3:1452\u201363.","journal-title":"Nat Cancer"},{"key":"8499_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/331091a0","volume":"331","author":"V Giguere","year":"1988","unstructured":"Giguere V, Yang N, Segui P, Evans RM. Identification of a new class of steroid hormone receptors. Nature. 1988;331:91\u20134.","journal-title":"Nature"},{"key":"8499_CR44","doi-asserted-by":"publisher","first-page":"e2006134","DOI":"10.1371\/journal.pbio.2006134","volume":"16","author":"L Wu","year":"2018","unstructured":"Wu L, Cao J, Cai WL, Lang SM, Horton JR, Jansen DJ, et al. KDM5 histone demethylases repress immune response via suppression of STING. PLoS Biol. 2018;16:e2006134.","journal-title":"PLoS Biol"},{"key":"8499_CR45","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1016\/j.scib.2025.09.044","volume":"70","author":"ZZ Zheng","year":"2025","unstructured":"Zheng ZZ, Chen L, Hu GS, Peng BL, Huang QX, Wang A, et al. Nuclear receptor ESRRA promotes ER\u03b1-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programs. Sci Bull. 2025;70:3822\u201339.","journal-title":"Sci Bull"},{"key":"8499_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrc3396","volume":"13","author":"G Deblois","year":"2013","unstructured":"Deblois G, Gigu\u00e8re V. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat Rev Cancer. 2013;13:27\u201336.","journal-title":"Nat Rev Cancer"},{"key":"8499_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12156","volume":"7","author":"G Deblois","year":"2016","unstructured":"Deblois G, Smith HW, Tam IS, Gravel SP, Caron M, Savage P, et al. ERRalpha mediates metabolic adaptations driving lapatinib resistance in breast cancer. Nat Commun. 2016;7:12156.","journal-title":"Nat Commun"},{"key":"8499_CR48","doi-asserted-by":"publisher","first-page":"6406","DOI":"10.1038\/s41388-020-01438-1","volume":"39","author":"M Vernier","year":"2020","unstructured":"Vernier M, McGuirk S, Dufour CR, Wan L, Audet-Walsh E, St-Pierre J, et al. Inhibition of DNMT1 and ERRalpha crosstalk suppresses breast cancer via derepression of IRF4. Oncogene. 2020;39:6406\u201320.","journal-title":"Oncogene"},{"key":"8499_CR49","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/1878-0261.13013","volume":"16","author":"K Danza","year":"2022","unstructured":"Danza K, Porcelli L, De Summa S, Di Fonte R, Pilato B, Lacalamita R, et al. The ERRalpha-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR-CYP24A1-ERRalpha overexpression correlates with poor prognosis in patients with basal-like breast cancer. Mol Oncol. 2022;16:904\u201320.","journal-title":"Mol Oncol"},{"key":"8499_CR50","doi-asserted-by":"publisher","first-page":"e0283047","DOI":"10.1371\/journal.pone.0283047","volume":"18","author":"D Musheyev","year":"2023","unstructured":"Musheyev D, Miller E, Birnbaum N, Miller E, Erblich S, Schuck A, et al. Inhibition of ERK signaling for treatment of ERRalpha positive TNBC. PLoS ONE. 2023;18:e0283047.","journal-title":"PLoS ONE"},{"key":"8499_CR51","first-page":"247","volume":"4","author":"J Hou","year":"2012","unstructured":"Hou J, Wu J, Dombkowski A, Zhang K, Holowatyj A, Boerner JL, et al. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. Am J Transl Res. 2012;4:247\u201356.","journal-title":"Am J Transl Res"},{"key":"8499_CR52","first-page":"1267","volume":"38","author":"S Catchpole","year":"2011","unstructured":"Catchpole S, Spencer-Dene B, Hall D, Santangelo S, Rosewell I, Guenatri M, et al. PLU-1\/JARID1B\/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. Int J Oncol. 2011;38:1267\u201377.","journal-title":"Int J Oncol"},{"key":"8499_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2108-5","volume":"16","author":"OA Bamodu","year":"2016","unstructured":"Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, et al. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. BMC Cancer. 2016;16:160.","journal-title":"BMC Cancer"},{"key":"8499_CR54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.yexcr.2019.04.006","volume":"379","author":"ZG Zhang","year":"2019","unstructured":"Zhang ZG, Zhang HS, Sun HL, Liu HY, Liu MY, Zhou Z. KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming. Exp Cell Res. 2019;379:182\u201390.","journal-title":"Exp Cell Res"},{"key":"8499_CR55","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202500628R","volume":"39","author":"MM Montano","year":"2025","unstructured":"Montano MM, Yeh IJ, Ketchart W. cGAS\/STING-independent induction of type I interferon by inhibitors of the histone methylase KDM5B. FASEB J. 2025;39:e70629.","journal-title":"FASEB J"},{"key":"8499_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116494","volume":"272","author":"T Guan","year":"2024","unstructured":"Guan T, Zhang Y, Li S, Zhang W, Song Y, Li Y, et al. Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer. Eur J Med Chem. 2024;272:116494.","journal-title":"Eur J Med Chem"},{"key":"8499_CR57","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","volume":"598","author":"SM Zhang","year":"2021","unstructured":"Zhang SM, Cai WL, Liu X, Thakral D, Luo J, Chan LH, et al. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature. 2021;598:682\u20137.","journal-title":"Nature"},{"key":"8499_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156451","volume":"175","author":"X Li","year":"2024","unstructured":"Li X, Li J, Liu Y, Sun L, Tai Q, Gao S, et al. Inhibition of KDM5B participates in immune microenvironment remodeling in pancreatic cancer by inducing STING expression. Cytokine. 2024;175:156451.","journal-title":"Cytokine"},{"key":"8499_CR59","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.molcel.2018.03.006","volume":"70","author":"WW Gao","year":"2018","unstructured":"Gao WW, Xiao RQ, Zhang WJ, Hu YR, Peng BL, Li WJ, et al. JMJD6 licenses eralpha-dependent enhancer and coding gene activation by modulating the recruitment of the CARM1\/MED12 co-activator complex. Mol Cell. 2018;70:340\u201357.e8.","journal-title":"Mol Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08499-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:03:24Z","timestamp":1771520604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08499-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8499"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08499-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}